Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Endoxifen, 4-Hydroxytamoxifen and an Estrogenic Derivative Modulate Estrogen Receptor Complex Mediated Apoptosis in Breast Cancer.

Maximov PY, Abderrahman B, Fanning SW, Sengupta S, Fan P, Curpan RF, Quintana Rincon DM, Greenland JA, Rajan SS, Greene GL, Jordan VC.

Mol Pharmacol. 2018 May 8. pii: mol.117.111385. doi: 10.1124/mol.117.111385. [Epub ahead of print]

2.

Telling details of breast-cancer recurrence.

Abderrahman B, Jordan VC.

Nature. 2018 Jan 11;553(7687):155. doi: 10.1038/d41586-018-00399-6. No abstract available.

PMID:
29323320
3.

A unifying biology of sex steroid-induced apoptosis in prostate and breast cancers.

Maximov PY, Abderrahman B, Curpan RF, Hawsawi YM, Fan P, Jordan VC.

Endocr Relat Cancer. 2018 Feb;25(2):R83-R113. doi: 10.1530/ERC-17-0416. Epub 2017 Nov 21. Review.

4.

Rethinking Extended Adjuvant Antiestrogen Therapy to Increase Survivorship in Breast Cancer.

Abderrahman B, Jordan VC.

JAMA Oncol. 2018 Jan 1;4(1):15-16. doi: 10.1001/jamaoncol.2017.3510. No abstract available.

PMID:
29145574
5.

Angela M. Hartley Brodie (1934-2017).

Abderrahman B, Jordan VC.

Nature. 2017 Aug 2;548(7665):32. doi: 10.1038/548032a. No abstract available.

PMID:
28770835
6.

Opportunities and challenges of long term anti-estrogenic adjuvant therapy: treatment forever or intermittently?

Bhattacharya P, Abderrahman B, Jordan VC.

Expert Rev Anticancer Ther. 2017 Apr;17(4):297-310. doi: 10.1080/14737140.2017.1297233. Epub 2017 Mar 10.

PMID:
28281842
7.

To the Editor.

Abderrahman B.

Menopause. 2017 Apr;24(4):471. doi: 10.1097/GME.0000000000000854. No abstract available.

PMID:
28195996
8.

Tamoxifen Decreases Mortality, but How?

Bhattacharya P, Abderrahman B, Jordan VC.

J Clin Oncol. 2017 Jan 20;35(3):379. doi: 10.1200/JCO.2016.69.1618. Epub 2016 Oct 31. No abstract available.

PMID:
28095275
9.

Long-term Adjuvant Tamoxifen Therapy and Decreases in Contralateral Breast Cancer.

Abderrahman B, Jordan VC.

JAMA Oncol. 2016 Oct 6. doi: 10.1001/jamaoncol.2016.3324. [Epub ahead of print] No abstract available.

PMID:
27711910
10.

Sex steroid induced apoptosis as a rational strategy to treat anti-hormone resistant breast and prostate cancer.

Jordan VC, Fan P, Abderrahman B, Maximov PY, Hawsawi YM, Bhattacharya P, Pokharel N.

Discov Med. 2016 May;21(117):411-27.

11.

Estrogen Deprivation Therapy in Ovarian Cancer: An Opportunity.

Abderrahman B, Jordan VC.

J Clin Oncol. 2016 Aug 1;34(22):2675-6. doi: 10.1200/JCO.2016.67.3137. Epub 2016 May 23. No abstract available.

PMID:
27217463
12.

t(9;22) as secondary alteration in core-binding factor de novo acute myeloid leukemia.

Vitale C, Lu X, Abderrahman B, Takahashi K, Ravandi F, Jabbour E.

Am J Hematol. 2015 Nov;90(11):E211-2. doi: 10.1002/ajh.24143. Epub 2015 Oct 12. No abstract available.

13.

The molecular, cellular and clinical consequences of targeting the estrogen receptor following estrogen deprivation therapy.

Fan P, Maximov PY, Curpan RF, Abderrahman B, Jordan VC.

Mol Cell Endocrinol. 2015 Dec 15;418 Pt 3:245-63. doi: 10.1016/j.mce.2015.06.004. Epub 2015 Jun 5. Review.

14.

Influence of exercise intensity on time spent at high percentage of maximal oxygen uptake during an intermittent session in young endurance-trained athletes.

Thevenet D, Tardieu M, Zouhal H, Jacob C, Abderrahman BA, Prioux J.

Eur J Appl Physiol. 2007 Dec;102(1):19-26. Epub 2007 Sep 13.

PMID:
17851682
15.

Antiulcerogenic activity of Zizyphus lotus (L.) extracts.

Wahida B, Abderrahman B, Nabil C.

J Ethnopharmacol. 2007 Jun 13;112(2):228-31. Epub 2007 Mar 4.

PMID:
17408894

Supplemental Content

Loading ...
Support Center